Nimble collaborates to discover compounds for SARS-CoV-2 diagnostics
Nimble Therapeutics, Inc. today announced a collaboration with Roche Diagnostics to accelerate discovery of novel peptide-based molecules for the development of SARS-CoV-2 ...
May 07